Another study showed that the inhibition of the β1 integrin activity by monoclonal antibody AIIB2 markedly promotes radiotherapy efficacy and elevates sensitivity to HER2‐targeting agents of breast cancer cells.265, 266. Here, ERBB2 is linked to breast cancer.